Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst

Hanne H Brorson, Espen Ajo Arnevik, Kim Rand, Hanne H Brorson, Espen Ajo Arnevik, Kim Rand

Abstract

Background and aims: There is an urgent need for tools allowing therapists to identify patients at risk of dropout. The OQ-Analyst, an increasingly popular computer-based system, is used to track patient progress and predict dropout. However, we have been unable to find empirical documentation regarding the ability of OQ-Analyst to predict dropout. The aim of the present study was to perform the first direct test of the ability of the OQ-Analyst to predict dropout.

Design: Patients were consecutively enlisted in a naturalistic, prospective, longitudinal clinical trial. As interventions based on feedback from the OQ-Analyst could alter the outcome and potentially render the prediction wrong, feedback was withheld from patients and therapists.

Setting: The study was carried out during 2011-2013 in an inpatient substance use disorder clinic in Oslo, Norway.

Participants: Patients aged 18 to 28 years who met criteria for a principal diagnosis of mental or behavioural disorder due to psychoactive substance use (ICD 10; F10.2-F19.2).

Measurements: Red signal (predictions of high risk) from the Norwegian version of the OQ-Analyst were compared with dropouts identified using patient medical records as the standard for predictive accuracy.

Findings: A total of 40 patients completed 647 OQ assessments resulting in 46 red signals. There were 27 observed dropouts, only one of which followed after a red signal. Patients indicated by the OQ-Analyst as being at high risk of dropping out were no more likely to do so than those indicated as being at low risk. Random intercept logistic regression predicting dropout from a red signal was statistically nonsignificant. Bayes factor supports no association.

Conclusions: The study does not support the predictive ability of the OQ-Analyst for the present patient population. In the absence of empirical evidence of predictive ability, it may be better not to assume such ability.

Keywords: OQ-45; OQ-Analyst; attrition; dropout; feedback technology; negative treatment outcome; prediction; progress monitoring; substance use disorder treatment.

Conflict of interest statement

Declaration of conflicting interest:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Simulation-based power estimates (y-axis) from runs with varying numbers of participants (delineated by colour), varying assumed sensitivity of ‘red signal’ to subsequent dropout (x-axis). Lines represent generalised linear models with a logit link, predicting observed powers for each number of simulated respondents by varying sensitivity.
Figure 2.
Figure 2.
Flow chart compliant with STARD showing patient recruitment, OQ-Analyst predictions and observations extracted from medical journals.
Figure 3.
Figure 3.
Length of stay (x-axis) for included patients, sorted by total length of stay. Red x denotes dropout, blue triangle completed treatment. Red reflects red signal, grey otherwise. No line indicates that patient was not admitted, for example, due to dropout or out on leave. Treatment cessation with no marker due to any other reason, such as the patient being moved to another ward.
Figure 4.
Figure 4.
Simulation-based Bayes factor estimates based on assumed prior relative risk of dropout following ‘red signal’ and the observed patient data. The line is a fitted exponential curve on risk. BF01 falls below with assumed prior relative risks exceeding approximately 1.9.

References

    1. Alterman AI, McKay JR, Mulvaney FD, McLellan AT. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend. 1996;40(3):227–233.
    1. Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. RESEARCH REPORT A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998;93(1):73–92.
    1. Moos RH, Pettit B, Gruber VA. Characteristics and outcomes of three models of community residential care for abuse patients. J Subst Abuse. 1995;7(1):99–116.
    1. Simpson DD. Treatment for drug abuse: Follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981;38(8):875–880.
    1. United Nations Office on Drugs and Crime. World Drug Report 2012. Austria: United Nations; 2012. . Accessed November 30, 2012.
    1. Dalsbø TK, Hammerstrøm KT, Vist GEet al. Psychosocial interventions for retention in drug abuse treatment. Cochrane Database Syst Rev. 2010;(1):CD008220. doi:10.1002/14651858.CD008220
    1. Ravndal E, Vaglum P, Lauritzen G. Completion of long-term inpatient treatment of drug abusers: a prospective study from 13 different units. European addiction research. 2005;11(4):180.
    1. Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010–1024.
    1. Stark MJ. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev. 1992;12(1):93–116.
    1. Craig RJ. Reducing the treatment drop out rate in drug abuse programs. J Subst Abuse Treat. 1985;2(4):209–219.
    1. Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975;82(5):738–783.
    1. Cacciola JS, Alterman AI, Dephilippis Det al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44(3):256–263.
    1. Lambert MJ. Helping clinicians to use and learn from research-based systems: the OQ-analyst. Psychotherapy. 2012;49(2):109.
    1. Pulford J, EDeering D, Robinson Get al. Development of a routine outcome monitoring instrument for use with clients in the New Zealand alcohol and other drug treatment. Sector: the Alcohol and Drug Outcome Measure (ADOM). (The Drug and Alcohol Outcome Measure (ADOM)). 2010. . Accessed August 30, 2014.
    1. Howard KI, Kopta Mark S, Krause MS, Orlinsky DE. The dose–effect relationship in psychotherapy. Am Psychol. 1986;41(2):159–164.
    1. McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62(1):9–17.
    1. Ackerman SJ, Benjamin LS, Beutler LEet al. Empirically supported therapy relationships: conclusions and recommendations fo the Division 29 Task Force. Psychother Theor Res Pract Train. 2001;38(4):495–497.
    1. Lambert MJ, Hansen NB, Finch AE. Patient-focused research: using patient outcome data to enhance treatment effects. J Consult Clin Psychol. 2001;69(2):159.
    1. Whipple JL, Lambert MJ, Vermeersch DA, Smart DW, Nielsen SL, Hawkins EJ. Improving the effects of psychotherapy: the use of early identification of treatment failure and problem-solving strategies in routine practice. J Couns Psychol. 2003;50(1):59–68.
    1. Duncan BL, Miller SD, Sparks JA. The Heroic Client: A Revolutionary Way to Improve Effectiveness through Client-Directed, Outcome-Informed Therapy. Hoboken, NJ: John Wiley & Sons; 2004.
    1. Miller SD, Duncan BL, Brown J, Sorrell R, Chalk MB. Using formal client feedback to improve retention and outcome: making ongoing, real-time assessment feasible. Journal of Brief Therapy. 2006;5(1):5–22.
    1. Goodman JD, McKay JR, DePhilippis D. Progress monitoring in mental health and addiction treatment: a means of improving care. Prof Psychol Res Pract. 2013;44(4):231–246.
    1. Conijn JM, Emons WHM, De Jong K, Sijtsma K. Detecting and explaining aberrant responding to the outcome questionnaire-45. Assessment. 2015;22(4):513–524.
    1. Lambert MJ. Administration and Scoring Manual for the OQ-45.2 (Outcome Questionnaire). OQ Measures, LLC; 2004.
    1. Hatfield DR, Ogles BM. The use of outcome measures by psychologists in clinical practice. Prof Psychol Res Pract. 2004;35(5):485.
    1. Samantha.Elliott. NREPP. . Published May 27, 2014. Accessed June 14, 2018.
    1. Lambert MJ, Whipple JL, Vermeersch DAet al. Enhancing psychotherapy outcomes via providing feedback on client progress: a replication. Clin Psychol Psychother. 2002;9(2):91–103.
    1. Lambert M. Presidential address: what we have learned from a decade of research aimed at improving psychotherapy outcome in routine care. Psychother Res. 2007;17(1):1–14.
    1. Hannan C, Lambert MJ, Harmon Cet al. A lab test and algorithms for identifying clients at risk for treatment failure. J Clin Psychol. 2005;61(2):155–163.
    1. Ellsworth JR, Lambert MJ, Johnson J. A comparison of the outcome questionnaire-45 and outcome questionnaire-30 in classification and prediction of treatment outcome. Clin Psychol Psychother. 2006;13(6):380–391.
    1. Lambert MJ, Whipple JL, Bishop MJ, Vermeersch DA, Gray GV, Finch AE. Comparison of empirically-derived and rationally-derived methods for identifying patients at risk for treatment failure. Clin Psychol Psychother. 2002;9(3):149–164.
    1. Lutz W, Lambert MJ, Harmon SC, Tschitsaz A, Schürch E, Stulz N. The probability of treatment success, failure and duration – what can be learned from empirical data to support decision making in clinical practice? Clin Psychol Psychother. 2006;13(4):223–232.
    1. Percevic R, Lambert MJ, Kordy H. What is the predictive value of responses to psychotherapy for its future course? Empirical explorations and consequences for outcome monitoring. Psychother Res. 2006;16(3):364–373.
    1. Spielmans GI, Masters KS, Lambert MJ. A comparison of rational versus empirical methods in the prediction of psychotherapy outcome. Clin Psychol Psychother. 2006;13(3):202–214.
    1. Amble I, Gude T, Stubdal Set al. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context [published online ahead of print November 5, 2013.]. Psychother Res. doi:10.1080/10503307.2013.849016
    1. Snell MN, Mallinckrodt B, Hill RD, Lambert MJ. Predicting counseling center clients’ response to counseling: a 1-year follow-up. J Couns Psychol. 2001;48(4):463–473.
    1. Vermeersch DA, Lambert MJ, Burlingame GM. Outcome questionnaire: item sensitivity to change. J Pers Assess. 2000;74(2):242–261.
    1. Alfandre DJ. ‘I’m Going Home’: discharges against medical advice. Mayo Clin Proc. 2009;84(3):255–260.
    1. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2015; ; . Accessed September 18, 2018.
    1. RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc., 2015. ; . Accessed September 18, 2018.
    1. Bates D, Maechler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.
    1. Bürkner P-C. brms: An R Package for Bayesian Multilevel Models Using Stan. J Stat Softw. 2017;80(1):1–28.
    1. Morey RD, Rouder JN. BayesFactor: Computation of Bayes Factors for Common Designs. R package version 0.9.12-4.2. 2018. . . Accessed September 18, 2018.
    1. Slone NC, Reese RJ, Mathews-Duvall S, Kodet J. Evaluating the efficacy of client feedback in group psychotherapy. Group Dyn Theor Res Pract. 2015;19(2):122.
    1. Conijn JM, Emons WHM, van Assen MALM, Pedersen SS, Sijtsma K. Explanatory, Multilevel Person-Fit Analysis of Response Consistency on the Spielberger State-Trait Anxiety Inventory. Multivariate Behav Res. 2013;48(5):692–718.
    1. Woods CM, Oltmanns TF, Turkheimer E. Detection of aberrant responding on a personality scale in a military sample: an application of evaluating person fit with two-level logistic regression. Psychol Assess. 2008;20(2):159–168.
    1. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
    1. Grant BF, Stinson FS, Dawson DAet al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807–816.
    1. Kedia S, Sell MA, Relyea G. Mono- versus polydrug abuse patterns among publicly funded clients. Subst Abuse Treat Prev Policy. 2007;2:33.
    1. Nordheim K, Walderhaug E, Alstadius S, Kern-Godal A, Arnevik E, Duckert F. Young adults’ reasons for dropout from residential substance use disorder treatment. Qual Soc Work. 2018;17(1):24–40.
    1. Miller SD, Duncan BL, Sorrell R, Brown GS. The partners for change outcome management system. J Clin Psychol. 2005;61(2):199–208.
    1. Saxon D, Barkham M, Foster A, Parry G. The Contribution of Therapist Effects to Patient Dropout and Deterioration in the Psychological Therapies. Clin Psychol Psychother. 24(3):575–588.
    1. Linden M. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother. 20(4):286–296.
    1. Bleeker SE, Moll HA, Steyerberg EWet al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003;56(9):826–832.

Source: PubMed

3
Předplatit